Arsenic trioxide effectively suppressed tumors with abnormal Hh activation, such as primary medulloblastoma, vismodegib-resistant medulloblastoma and Ewing sarcoma in vivo when used alone or in combination with SMO inhibitor (61, 175, 189). Here, SMO is linked to medulloblastoma.